10.02
price down icon2.24%   -0.23
 
loading

Immunome Inc Azioni (IMNM) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
37.22%
4.015
2.926 2.738 2.91 2.364
Operating Expenses
6.16%
50.49
47.56 85.71 53.43 42.37
Benefits Costs and Expenses
100.00%
-
44.57 82.99 - -
Costs And Expenses
13.30%
50.49
44.57 82.99 53.43 42.37
Provision For Loan, Lease, And Other Losses
-
- - - -
Operating Income/Loss
4.13%
-46.48
-44.64 -82.97 -50.52 -40.01
Net Interest Income/Expense
2.84%
3.081
2.996 2.721 3.422 3.887
Interest Income/Expense After Provision For Losses
2.84%
3.081
2.996 2.721 3.422 3.887
Income/Loss From Continuing Operations Before Tax
109.64%
4.015
-41.64 -80.25 2.91 -36.12
Income/Loss From Continuing Operations After Tax
4.22%
-43.40
-41.64 -80.25 -47.10 -36.12
Net Income/Loss
4.22%
-43.40
-41.64 -80.25 -47.10 -36.12
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
9.57%
87.01
79.41 1.3998 60.21 59.94
Diluted Average Shares
9.57%
87.01
79.41 1.3998 60.21 59.94
Basic Earnings Per Share
3.85%
-0.50
-0.52 -1.28 -0.78 -0.60
Diluted Earnings Per Share
3.85%
-0.50
-0.52 -1.28 -0.78 -0.60
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$36.00
price up icon 0.22%
$85.46
price up icon 0.64%
$25.35
price down icon 3.58%
$111.40
price down icon 1.02%
$127.21
price down icon 0.05%
biotechnology ONC
$312.51
price down icon 2.13%
Capitalizzazione:     |  Volume (24 ore):